FEB 2026
AUSTRALIA’S LEADING OPHTHALMIC MAGAZINE SINCE 1975
FEBRUARY 2026
DISCOVER MORE LIGHT UTILISATION WITH LESS SCATTER†1,2 Everything you love about PanOptix®, now with half the scatter‡2,3 thanks to an unprecedented 94% light utilisation.§1-3 The lowest light scatter of any trifocal IOL.†§1-8 Clareon® PanOptix® Pro. Vision to the Power of Pro. †Compared to Clareon® PanOptix®. Based on bench and vision simulator studies. ‡Compared to Clareon® PanOptix®. PanOptix has 88% light utilisation (12% scatter light)/PanOptix Pro 94% light utilisation (6% scatter light). §Based on manufacturer reported values and respective methodology for trifocals Clareon® PanOptix®, Envista Envy*, Gemetric, Rayner* Trifocal and AT Elana*. *Trademarks are the property of their respective owners. References: 1. Alcon data on file, 2024; [REF-25221]. 2. Alcon data on file, 2025; [REF-25218]. 3. Alcon data on file, 2025; [REF-08546]. 4. Muzychuk, A. Defocus Curve Performance of a Novel Hydrophobic Acrylic Trifocal Intraocular Lens: A prospective, Multicenter Canadian Study. ASCRS Annual Meeting, April 5-8, Boston; [REF-25948]. 5. Rayner Professional Website. https://rayner.com/en/iol/trifocal/rayone-trifocal/. Accessed December 2024. 6. Carones F. New Concept of Light Distribution for Bilateral Trifocal IOL Implantation. AAO. 2022;2022:53; [REF-23587]. 7. ZEISS AT LISA tri family. Supplement in Cataract and Refractive Surgery Today (Europe), September 2014. 8. Zeiss Cataract Insights: Laying the Myth or Reality; Digitalization enhances cataract surgery? Supplement in Ophthalmology Times, Europe; May 22, 2024; https://europe. ophthalmologytimes.com/zeiss-cataract-insight-series?page=1 Accessed December 2024. Please refer to relevant products instructions for use for complete list of indications, contraindications and warnings.
Australia's cohort of optometrists has increased – just not where they are needed, say leaders
GENERATION GAP Opportunities abound for those practices who know how to mind that gap and promote contact lenses
55
GROWING PAINS
19
WWW.INSIGHTNEWS.COM.AU
03
©2025 Alcon Laboratories Pty Ltd. AUS: 1800 224 153; Auckland NZ: 0800 101 106. ALC2561 12/25 ANZ-CPR-2500018
INJECTING DEBATE An eye health sector leader urges the Govt to press pause on changes to intravitreal injection policy